Figure 4.
Progression-free survival of 11 patients with p53-positive ARL and 16 patients with p53-negative ARL. Progression-free survival probabilities are 86% and 82%, respectively, at the median potential follow-up time of 53 months.
Progression-free survival of 11 patients with p53-positive ARL and 16 patients with p53-negative ARL. Progression-free survival probabilities are 86% and 82%, respectively, at the median potential follow-up time of 53 months.
